Conversely, most cases with SPG3 (92.3%), SPG4 (89.5%), SPG72 (85.7%), and SPG47 (80.0%) presented with an HSP-nMD phenotype. This evidence concerns the gene REEP2 and hereditary spastic paraplegia.